Atlas Trials

Advanced Non Squamous NSCLC

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Non Squamous NSCLC

RecordFirmDate
Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy (NCT04670913)Junling Li2021-06-28
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC (NCT04325698)Pfizer2020-06-11
Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006) (NCT03778853)LanZhou University2019-01-01
Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC (NCT03768037)Guangdong Association of Clinical Trials2018-11-26
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC (NCT00369070)Amgen2007-01-31

Track Advanced Non Squamous NSCLC automatically

Every clearance here is in the API, with alerts when new ones post.